Ashland launches condurango skin active backed by 30-person study
Free synopsis
Ashland has commercialised Forzango biofunctional, a condurango bark-derived ingredient aimed at personal-care products for active consumers. Its October 8, 2026 release combines a global product launch with a sourcing programme and results from a six-week, placebo-controlled study involving 30 men and women.
The full article is available to subscribers.
Products and related news
Request a free newsletter trial covering your products and business interests.
Request a free trialOur team will confirm activation and access. A trial request does not automatically unlock this article.